Issue navigation
Volume 18, Issue 6, June 2016
Editorials
PCV in low-grade gliomas: benefit from old drugs in an evolving disease entity
David Schiff
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 755–756, https://doi.org/10.1093/neuonc/now098
The promise of molecular profiling of choroid plexus tumors for diagnostic and prognostic stratification: where to go from here?
Devorah Segal and Matthias A. Karajannis
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 757–758, https://doi.org/10.1093/neuonc/now048
Fatigue randomized controlled trials—how tired is “too tired” in patients undergoing glioma treatment?
Robin Grant and Paul D. Brown
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 759–760, https://doi.org/10.1093/neuonc/now052
Highlights from the Literature
Highlights from the Literature
Sean Lawler and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 761–763, https://doi.org/10.1093/neuonc/now104
Invited Reviews
Atypical teratoid/rhabdoid tumors—current concepts, advances in biology, and potential future therapies
Michael C. Frühwald and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 764–778, https://doi.org/10.1093/neuonc/nov264
Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy
Terri S. Armstrong and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 779–789, https://doi.org/10.1093/neuonc/nov269
Basic and Translational Investigations
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups
Christian Thomas and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 790–796, https://doi.org/10.1093/neuonc/nov322
Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization
Jason H. Stafford and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 797–806, https://doi.org/10.1093/neuonc/nov272
CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients
Daniel Dubinski and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 807–818, https://doi.org/10.1093/neuonc/nov280
Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1
Fan Xuan and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 819–829, https://doi.org/10.1093/neuonc/nov281
Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis
Zhou Xu and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 830–839, https://doi.org/10.1093/neuonc/nov298
Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier
Kaijun Di and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 840–848, https://doi.org/10.1093/neuonc/nov299
CLINICAL INVESTIGATIONS
A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy
Eudocia Q. Lee and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 849–854, https://doi.org/10.1093/neuonc/now007
EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors
Bojana Milojkovic Kerklaan and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 855–862, https://doi.org/10.1093/neuonc/nov273
Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade
William L. Hwang and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 863–872, https://doi.org/10.1093/neuonc/nov285
Neuroimaging
A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation
Vaios Hatzoglou and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 873–880, https://doi.org/10.1093/neuonc/nov301
Pediatric Neuro-Oncology
Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma
Bree R. Eaton and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 881–887, https://doi.org/10.1093/neuonc/nov302
Letter to the Editor
Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas
Dominique Figarella-Branger and others
Neuro-Oncology, Volume 18, Issue 6, June 2016, Pages 888–890, https://doi.org/10.1093/neuonc/now085
News and Announcements
Society news
Neuro-Oncology, Volume 18, Issue 6, June 2016, Page 891, https://doi.org/10.1093/neuonc/now103
Advertisement
Advertisement